Literature DB >> 12606510

Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility.

Hong Lan1, Mary E Rabaglia, Jonathan P Stoehr, Samuel T Nadler, Kathryn L Schueler, Fei Zou, Brian S Yandell, Alan D Attie.   

Abstract

Obesity is a strong risk factor for the development of type 2 diabetes. We have previously reported that in adipose tissue of obese (ob/ob) mice, the expression of adipogenic genes is decreased. When made genetically obese, the BTBR mouse strain is diabetes susceptible and the C57BL/6J (B6) strain is diabetes resistant. We used DNA microarrays and RT-PCR to compare the gene expression in BTBR-ob/ob versus B6-ob/ob mice in adipose tissue, liver, skeletal muscle, and pancreatic islets. Our results show: 1) there is an increased expression of genes involved in inflammation in adipose tissue of diabetic mice; 2) lipogenic gene expression was lower in adipose tissue of diabetes-susceptible mice, and it continued to decrease with the development of diabetes, compared with diabetes-resistant obese mice; 3) hepatic expression of lipogenic enzymes was increased and the hepatic triglyceride content was greatly elevated in diabetes-resistant obese mice; 4) hepatic expression of gluconeogenic genes was suppressed at the prediabetic stage but not at the onset of diabetes; and 5) genes normally not expressed in skeletal muscle and pancreatic islets were expressed in these tissues in the diabetic mice. We propose that increased hepatic lipogenic capacity protects the B6-ob/ob mice from the development of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606510     DOI: 10.2337/diabetes.52.3.688

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  53 in total

1.  Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival.

Authors:  Jeremy A Lavine; Philipp W Raess; Donald S Stapleton; Mary E Rabaglia; Joshua I Suhonen; Kathryn L Schueler; James E Koltes; John A Dawson; Brian S Yandell; Linda C Samuelson; Margery C Beinfeld; Dawn Belt Davis; Marc K Hellerstein; Mark P Keller; Alan D Attie
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

Review 2.  Physiological insights gained from gene expression analysis in obesity and diabetes.

Authors:  Mark P Keller; Alan D Attie
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

Review 3.  Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?

Authors:  Anne P L Jensen-Urstad; Clay F Semenkovich
Journal:  Biochim Biophys Acta       Date:  2011-10-08

Review 4.  The lipin protein family: dual roles in lipid biosynthesis and gene expression.

Authors:  Karen Reue; Peixiang Zhang
Journal:  FEBS Lett       Date:  2007-11-20       Impact factor: 4.124

5.  Combining classical trait and microarray data to dissect transcriptional regulation: a case study.

Authors:  Dong Wang; Dan Nettleton
Journal:  Theor Appl Genet       Date:  2008-01-09       Impact factor: 5.699

6.  Systems genetics of susceptibility to obesity-induced diabetes in mice.

Authors:  Richard C Davis; Atila van Nas; Lawrence W Castellani; Yi Zhao; Zhiqiang Zhou; Pingzi Wen; Suzanne Yu; Hongxiu Qi; Melenie Rosales; Eric E Schadt; Karl W Broman; Miklós Péterfy; Aldons J Lusis
Journal:  Physiol Genomics       Date:  2011-10-18       Impact factor: 3.107

7.  Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity.

Authors:  Jifeng Zhang; Mingui Fu; Taixing Cui; Chen Xiong; Kefeng Xu; Wei Zhong; Yan Xiao; Donna Floyd; Jian Liang; En Li; Qing Song; Yuqing E Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients.

Authors:  T Takamura; M Sakurai; T Ota; H Ando; M Honda; S Kaneko
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

9.  Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS-db/db mice.

Authors:  Richard C Davis; Lawrence W Castellani; Maryam Hosseini; Osnat Ben-Zeev; Hui Z Mao; Michael M Weinstein; Dae Young Jung; John Y Jun; Jason K Kim; Aldons J Lusis; Miklós Péterfy
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

10.  Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death.

Authors:  Junqin Chen; Ghislaine Fontes; Geetu Saxena; Vincent Poitout; Anath Shalev
Journal:  Diabetes       Date:  2009-10-29       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.